Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • Full September 1, 2003 Issue in PDF

  • Personnel File

    John Babitt has been named president, chief operating officer and chief financial officer of CABG Medical (Minneapolis, Minnesota). Babitt previously was an executive with BioHeart. CABG Medical develops coronary bypass devices and related items designed for use in heart surgery.
  • Market Updates

    Endovascular physicians and interventional cardiologists are overwhelmingly likely to use drug-eluting stents (DES) more often in the future because they believe their costs will decrease as competition among manufacturers increases.
  • Report from Europe

    Eucomed (Brussels, Belgium), the European medical technology trade association, has developed a computerized health economic model to explore the cost-effectiveness of cardiac resynchronization therapy (CRT) as compared to traditional pharmaceutical treatment for heart failure.
  • Necessity drives new use for CardioTech’s synthetic graft

    As is often the case with science-based medicine, many great discoveries are made entirely by accident or out of an urgent necessity. Falling into the latter category was CardioTech Internationals (Woburn, Massachusetts) first pediatric implant of a synthetic coronary artery bypass graft (CABG), the first of its kind in the world.
  • Stroke prevention devices in ‘Summer in Seattle’ spotlight

    SEATTLE, Washington Beginning with the advent of percutaneous transluminal coronary angioplasty (PTCA) about 20 years ago, the interventional cardiology (IC) market has grown rapidly, fueled by relentless and impressive innovation.
  • Legal Review & Commentary: Baby’s delay leads to $19 million settlement

    One summer morning, a pregnant woman was admitted to a hospital with irregular contractions. The hospital nursing staff initiated a fetal heart monitor; and by midafternoon, the fetuss heart rate was decelerating. However, when an obstetrician called to check on the patient, the nursing staff told him everything was fine.
  • Your quality info to be made public soon

    The effect of Home Health Compare, the Centers for Medicare & Medicaid Services web site that publicizes results of 11 home health quality indicators, has been minimal for agencies located in the eight pilot test states.
  • Pharmacology Watch: Study Shows Oral IIb/IIIa Receptors Increase Mortality

    Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.
  • ECG Review: Concealing the Cause

    The 12-lead ECG and accompanying rhythm strip in the Figure were obtained from an asymptomatic and otherwise healthy 53-year-old man. What two things are unusual about the beat marked X? Did first degree AV block suddenly develop for the following sinus-conducted beat (beat Y)?